Fin Trust Capital Advisors, LLC Harvard Bioscience Inc Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding HBIO
# of Institutions
97Shares Held
31.3MCall Options Held
0Put Options Held
15K-
Black Rock Inc. New York, NY2.84MShares$1.71 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$1.65 Million0.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$1.61 Million0.66% of portfolio
-
Amh Equity LTD2.5MShares$1.5 Million5.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$1.29 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $25M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...